A carregar...
Ipilimumab Pharmacotherapy in Patients with Metastatic Melanoma
Immune augmentation with ipilimumab, an anti-CTLA-4 monoclonal antibody, has joined the ranks of approved immunologic agents for the treatment of metastatic melanoma. Phase III studies of ipilimumab in metastatic melanoma have demonstrated an overall survival advantage as compared to other approved...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Libertas Academica
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3418148/ https://ncbi.nlm.nih.gov/pubmed/22904648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S7245 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|